TG Therapeutics Strikes Global Alliance To Develop Novel BET Inhibitors For Hematological Malignancies Treatment

By: via Benzinga
TG Therapeutics, Inc. (NASDAQ: TGTX), revealed Friday that as part of a broader agreement with Jubilant Biosys, an Indian biotech ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.